谷歌浏览器插件
订阅小程序
在清言上使用

A Phase II Study of Navitoclax (ABT-263) As Single Agent in Women Heavily Pretreated for Recurrent Epithelial Ovarian Cancer: the MONAVI – GINECO Study

Gynecologic Oncology(2022)

引用 7|浏览57
暂无评分
关键词
Ovarian cancer,BH3 mimetics,Platinum resistance,Early phase study
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要